BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Multiplicom Launches Three New Mutation Detection Kits to Enable the Implementation of Personalized Cancer Treatment

  September 30, 2013

   · 

  3 min read
• Business

  Pfizer Inc. Grabs Autoimmune Diseases Drug Rights From Gliknik Inc. for $25 Million Upfront

  September 30, 2013

   · 

  2 min read
• Deals

  Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Agree to Merge Operations to Form One Company

  September 30, 2013

   · 

  4 min read
• Drug Development

  Genentech’s Kadcyla Boosts Breast Cancer Suvival Compared to Other Drugs in Phase 3 Study

  September 30, 2013

   · 

  10 min read
• Deals

  Rotech Healthcare Inc. Successfully Completes Financial Restructuring and Emerges From Chapter 11

  September 30, 2013

   · 

  3 min read
• Drug Development

  Amgen Touts Phase 3 Trial Data Comparing Vectibix® to Erbitux®

  September 30, 2013

   · 

  13 min read
• BioCapital

  U.S. Defense Dept. Awards $84 Million in Contracts to Medical Device COs Such as Cardinal Health, Inc., Henry Schein, Inc.. Abaxis, Inc. adnd Hospira, Inc.

  September 30, 2013

   · 

  1 min read
• FDA

  Thermo Fisher Scientific’s Xpect Flu A&B Assay Achieves FDA Clearance for Novel Avian Influenza A (H7N9) Analytical Reactivity Label Claims

  September 30, 2013

   · 

  2 min read
• Business

  VIVUS, Inc. President to Quit Oct. 12

  September 30, 2013

   · 

  1 min read
• Job Trends

  Lundbeck Inc. Reorganization to Affect Up to 200 Staffers

  September 30, 2013

   · 

  5 min read